BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 28056829)

  • 1. Seroprevalence and determinants of toxoplasmosis in pregnant women attending antenatal clinic at the university teaching hospital, Lusaka, Zambia.
    Frimpong C; Makasa M; Sitali L; Michelo C
    BMC Infect Dis; 2017 Jan; 17(1):10. PubMed ID: 28056829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serological survey and risk factors associated with
    Zakari MM; Isah AY; Offiong R; Yunusa T; Abdullahi IN
    Malawi Med J; 2020 Sep; 32(3):160-167. PubMed ID: 33488988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroepidemiology of Toxoplasma gondii infection in women of child-bearing age in central Ethiopia.
    Gebremedhin EZ; Abebe AH; Tessema TS; Tullu KD; Medhin G; Vitale M; Di Marco V; Cox E; Dorny P
    BMC Infect Dis; 2013 Feb; 13():101. PubMed ID: 23442946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of toxoplasmosis and risk factors of Toxoplasma gondii infection among pregnant women in Sri Lanka: a cross sectional study.
    Iddawela D; Vithana SMP; Ratnayake C
    BMC Public Health; 2017 Dec; 17(1):930. PubMed ID: 29202747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sero-prevalence of toxoplasmosis among pregnant women attending an ante-natal clinic at a teaching hospital in Al Kharj, Saudi Arabia.
    Qamer S; Rizvi SSR; Raoof S; Kamal SM; Khan S
    Trop Biomed; 2020 Mar; 37(1):186-193. PubMed ID: 33612729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroprevalence of Toxoplasma gondii antibodies amongst pregnant women at the Lagos State University Teaching Hospital, Nigeria.
    Akinbami AA; Adewunmi AA; Rabiu KA; Wright KO; Dosunmu AO; Dada MO; Adeyemo TA
    Niger Postgrad Med J; 2010 Jun; 17(2):164-7. PubMed ID: 20539334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of Toxoplasma gondii IgG and IgM antibodies and associated risk factors in women of child-bearing age in Njinikom, NW Cameroon.
    Wam EC; Sama LF; Ali IM; Ebile WA; Aghangu LA; Tume CB
    BMC Res Notes; 2016 Aug; 9(1):406. PubMed ID: 27528009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence and risk factors of Toxoplasma gondii infection among pregnant women in Trinidad and Tobago.
    Ramsewak S; Gooding R; Ganta K; Seepersadsingh N; Adesiyun AA
    Rev Panam Salud Publica; 2008 Mar; 23(3):164-70. PubMed ID: 18397582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence and associated risk factors of toxoplasmosis in pregnant women in Hebron district, Palestine.
    Nijem KI; Al-Amleh S
    East Mediterr Health J; 2009; 15(5):1278-84. PubMed ID: 20214142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence of Toxoplasma gondii among pregnant women attending antenatal clinics at Hawassa University comprehensive specialized and Yirgalem General Hospitals, in Southern Ethiopia.
    Fenta DA
    BMC Infect Dis; 2019 Dec; 19(1):1056. PubMed ID: 31842783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and predictors of Toxoplasma gondii infection in pregnant women from Dhamar, Yemen.
    Al-Adhroey AH; Mehrass AAO; Al-Shammakh AA; Ali AD; Akabat MYM; Al-Mekhlafi HM
    BMC Infect Dis; 2019 Dec; 19(1):1089. PubMed ID: 31888517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxoplasmosis awareness, seroprevalence and risk behavior among pregnant women in the Gampaha district, Sri Lanka.
    Chandrasena N; Herath R; Rupasinghe N; Samarasinghe B; Samaranayake H; Kastuririratne A; de Silva NR
    Pathog Glob Health; 2016 Mar; 110(2):62-7. PubMed ID: 27092763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Awareness, knowledge and risk factors of
    Eroglu S; Asgin N
    J Obstet Gynaecol; 2021 Jul; 41(5):714-720. PubMed ID: 33045851
    [No Abstract]   [Full Text] [Related]  

  • 14. Toxoplasmosis seroprevalence in relation to knowledge and practice among pregnant women in Dhahran, Saudi Arabia.
    Elsafi SH; Al-Mutairi WF; Al-Jubran KM; Abu Hassan MM; Al Zahrani EM
    Pathog Glob Health; 2015; 109(8):377-82. PubMed ID: 26924348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of Anti-Toxoplasma gondii Antibodies Among Lebanese Pregnant Women.
    Nahouli H; El Arnaout N; Chalhoub E; Anastadiadis E; El Hajj H
    Vector Borne Zoonotic Dis; 2017 Dec; 17(12):785-790. PubMed ID: 29064352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study on Toxoplasma infection between Malaysian and Myanmar pregnant women.
    Andiappan H; Nissapatorn V; Sawangjaroen N; Nyunt MH; Lau YL; Khaing SL; Aye KM; Mon NC; Tan TC; Kumar T; Onichandran S; bin Mat Adenan NA
    Parasit Vectors; 2014 Dec; 7():564. PubMed ID: 25498432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence and associated risk factors of Toxoplasma gondii among Manchu pregnant women in northeastern China.
    Jiang RL; Ma LH; Ma ZR; Hou G; Zhao Q; Wu X
    Microb Pathog; 2018 Oct; 123():398-401. PubMed ID: 30063975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxoplasmosis among pregnant women: high seroprevalence and risk factors in Kinshasa, Democratic Republic of Congo.
    Doudou Y; Renaud P; Coralie L; Jacqueline F; Hypolite S; Hypolite M; Patrick M; Andreia Ida L; Van Sprundel M; Marleen B; Van Geertruyden JP; Pascal L
    Asian Pac J Trop Biomed; 2014 Jan; 4(1):69-74. PubMed ID: 24144134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence and risk factors of Toxoplasma gondii infection in pregnant women from Bobo Dioulasso, Burkina Faso.
    Bamba S; Cissé M; Sangaré I; Zida A; Ouattara S; Guiguemdé RT
    BMC Infect Dis; 2017 Jul; 17(1):482. PubMed ID: 28693432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Investigation on
    Yun F; Hui-Fang L; Min-Yuan S
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2016 Dec; 28(6):664-668. PubMed ID: 29469258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.